Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
Public ClinicalTrials.gov record NCT07613840. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Personalizing Post Surgical Thromboprophylaxis for Patients With Peripheral Artery Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical trial is to determine whether a personalised blood clot prevention plan is more effective than standard treatment in adults with peripheral artery disease (PAD) who have undergone a procedure to restore blood flow to their legs. The main questions it aims to answer are: * Does the personalized plan lower the rate of blood clots in the treated leg one year after the procedure? * Does the personalized plan lower rates of amputation, repeat procedures, bleeding, and death compared to standard treatment? Researchers will compare the personalized TARGET plan which uses a blood test to tailor each person's blood clot prevention medication to the standard treatment to see if the personalized approach works better. Participants will: * Be randomly assigned to either the personalized TARGET plan or standard treatment after their procedure * Have blood tests at 1 week and at 1, 3, 6, 9, and 12 months after their procedure * Have medications adjusted based on blood test results if assigned to the TARGET group
Study identification
- NCT ID
- NCT07613840
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 484 participants
Conditions and interventions
Conditions
Interventions
- Aspirin Drug
- Clopidogrel Drug
- Rivaroxaban Drug
- Thromboelastography with Platelet Mapping Device
- Ticagrelor Drug
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 28, 2025
- Primary completion
- Apr 28, 2027
- Completion
- Jun 29, 2027
- Last update posted
- May 28, 2026
2025 – 2027
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Recruiting |
| Salem Hospital (Mass General Brigham) | Salem | Massachusetts | 01970 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Amputation trials
Other public records listing Amputation. Sorted by last update posted; newest first. Not a recommendation.
- NCT06777511: Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated Prosthesis Patients Not yet recruiting
- NCT02395497: Human Penile Allotransplantation Recruiting
- NCT06391697: Magnetic Bead Tracking System and eOPRA Implant System With Bionic Prosthesis for Transtibial Amputees Active, not recruiting
- NCT03882073: A Novel Approach to Upper Extremity Amputation to Augment Volitional Control and Restore Proprioception Recruiting
- NCT07613502: Bio Leg: Advancing Mobility (BAM) Recruiting
- NCT06908538: Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07613840, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 28, 2026 · Synced Jul 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07613840 live on ClinicalTrials.gov.